168 related articles for article (PubMed ID: 12366619)
1. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications.
Ahmed A; Kiefe CI; Allman RM; Sims RV; DeLong JF
J Am Geriatr Soc; 2002 Oct; 50(10):1659-66. PubMed ID: 12366619
[TBL] [Abstract][Full Text] [Related]
2. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
Ahmed A; Centor RM; Weaver MT; Perry GJ
Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
[TBL] [Abstract][Full Text] [Related]
3. Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community.
Rochon PA; Sykora K; Bronskill SE; Mamdani M; Anderson GM; Gurwitz JH; Gill S; Tu JV; Laupacis A
J Gen Intern Med; 2004 Jun; 19(6):676-83. PubMed ID: 15209607
[TBL] [Abstract][Full Text] [Related]
4. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
Masoudi FA; Rathore SS; Wang Y; Havranek EP; Curtis JP; Foody JM; Krumholz HM
Circulation; 2004 Aug; 110(6):724-31. PubMed ID: 15289383
[TBL] [Abstract][Full Text] [Related]
5. Risk-treatment mismatch in the pharmacotherapy of heart failure.
Lee DS; Tu JV; Juurlink DN; Alter DA; Ko DT; Austin PC; Chong A; Stukel TA; Levy D; Laupacis A
JAMA; 2005 Sep; 294(10):1240-7. PubMed ID: 16160132
[TBL] [Abstract][Full Text] [Related]
6. Heart failure mortality among older Medicare beneficiaries: association with left ventricular function evaluation and angiotensin-converting enzyme inhibitor use.
Ahmed A; Maisiak R; Allman RM; DeLong JF; Farmer R
South Med J; 2003 Feb; 96(2):124-9. PubMed ID: 12630634
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
Gambassi G; Lapane KL; Sgadari A; Carbonin P; Gatsonis C; Lipsitz LA; Mor V; Bernabei R
Arch Intern Med; 2000 Jan; 160(1):53-60. PubMed ID: 10632305
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.
Mujib M; Patel K; Fonarow GC; Kitzman DW; Zhang Y; Aban IB; Ekundayo OJ; Love TE; Kilgore ML; Allman RM; Gheorghiade M; Ahmed A
Am J Med; 2013 May; 126(5):401-10. PubMed ID: 23510948
[TBL] [Abstract][Full Text] [Related]
9. Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.
Frances CD; Noguchi H; Massie BM; Browner WS; McClellan M
Arch Intern Med; 2000 Sep; 160(17):2645-50. PubMed ID: 10999979
[TBL] [Abstract][Full Text] [Related]
10. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
[TBL] [Abstract][Full Text] [Related]
11. Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
McDermott MM; Lee P; Mehta S; Gheorghiade M
Clin Cardiol; 1998 Apr; 21(4):261-8. PubMed ID: 9562936
[TBL] [Abstract][Full Text] [Related]
12. Use of angiotensin-converting enzyme inhibitors in elderly people with heart failure: prevalence and outcomes.
Pedone C; Pahor M; Carosella L; Bernabei R; Carbonin P;
J Gerontol A Biol Sci Med Sci; 2004 Jul; 59(7):716-21. PubMed ID: 15304537
[TBL] [Abstract][Full Text] [Related]
13. Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure.
Pilote L; Abrahamowicz M; Eisenberg M; Humphries K; Behlouli H; Tu JV
CMAJ; 2008 May; 178(10):1303-11. PubMed ID: 18458262
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
15. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
16. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors.
Philbin EF; Rocco TA; Lindenmuth NW; Ulrich K; Jenkins PL
Am J Med; 2000 Dec; 109(8):605-13. PubMed ID: 11099679
[TBL] [Abstract][Full Text] [Related]
17. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada.
Johnson D; Jin Y; Quan H; Cujec B
J Am Coll Cardiol; 2003 Oct; 42(8):1438-45. PubMed ID: 14563589
[TBL] [Abstract][Full Text] [Related]
18. Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?
Pedone C; Cecchi E; Matucci R; Pahor M; Carosella L; Bernabei R; Mugelli A;
Drugs Aging; 2005; 22(7):605-14. PubMed ID: 16491523
[TBL] [Abstract][Full Text] [Related]
19. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons > or = 65 years of age.
Krumholz HM; Vaccarino V; Ellerbeck EF; Kiefe C; Hennen J; Kresowik TF; Gold JA; Jencks SF; Radford MJ
Am J Cardiol; 1997 Mar; 79(5):581-6. PubMed ID: 9068512
[TBL] [Abstract][Full Text] [Related]
20. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
